Tech Company Financing Transactions
Remedy Robotics Funding Round
Remedy Robotics closed a $62 million Series B venture capital round on 11/16/2026. Investors included DCVC, Blackbird Ventures and Build Collective.
Transaction Overview
Company Name
Announced On
11/16/2026
Transaction Type
Venture Equity
Amount
$62,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to accelerate a planned pivotal clinical trial in partnership with the University of California, advance toward FDA approval for neurovascular intervention, deploy prototype N1 Systems across its clinical partner network, and further develop its AI capabilities and autonomous functions.
Company Information
Company Status
Private & Independent
Industry
Robotics
Mailing Address
340 Kansas St
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Undisclosed
Website
Email Address
Overview
Cardiovascular disease kills more people than all cancers combined. Fewer than 3% of patients have access to the best care. Remedy Robotics has brought together pioneering clinicians and world-leading engineers, with backing from visionary investors, to change this.
Management Team
Browse more venture capital transactions:
Prev: 11/16/2026: Edra venture capital transaction
Next: 11/16/2026: Q/C Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








